These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 664911)

  • 1. [Studies on the pharmacokinetics of Sulfaclomid, Mebacid, Nevigramon and Metindol in patients with reduced kidney function].
    Traeger A; Stein G
    Z Urol Nephrol; 1978 Apr; 71(4):257-62. PubMed ID: 664911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of sulfaclomide and sulfamerazine in patients with impaired renal function after first and after repeated application.
    Traeger A; Stein G
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):315-20. PubMed ID: 892948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of sulfaclomide in man under therapeutically relevant conditions].
    Meyer FP; Walther H
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):340-5. PubMed ID: 892952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The kinetics of sulfamerazine (Mebacid) and the effect of sulfamerazine therapy on p-aminohippuric acid clearance in pregnancy].
    Peiker G; Traeger A; Nöschel H
    Zentralbl Gynakol; 1976; 98(16):970-5. PubMed ID: 973491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of renal and urogenital infections with Nevigramon (nalidixic acid).
    Kondás J
    Ther Hung; 1971; 19(3):113-5. PubMed ID: 5139847
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetics of sulfamerazine, sulfamethoxypyridazine and sulfaclomide in young and adult rats].
    Bräunlich H; Splinter FK
    Acta Biol Med Ger; 1974; 32(2-3):235-47. PubMed ID: 4423849
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the kinetics of sulfaclomide and the effect of sulfaclomide therapy on p-aminohippuric acid clearance in pregnancy].
    Peiker G; Traeger A; Nöschel H; Bonow A; Hertel U
    Zentralbl Gynakol; 1975; 97(10):612-8. PubMed ID: 1189751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic model studies of sulfamerazine in domestic mammals. 2. Elimination of Mebacid 200 and Mebacid tablets following oral, subcutaneous and intramuscular administration].
    Losch K; Heinze W; Mieth K; Lender S
    Arch Exp Veterinarmed; 1980; 34(3):451-9. PubMed ID: 7053163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of indomethacin and indomethacin metabolites administered continuously to patients with healthy or damaged kidneys].
    Stein G; Kunze M; Zaumseil J; Traeger A
    Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):470-3. PubMed ID: 924701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetic model studies of sulfamerazine in domestic mammals. 4. Mebacid tablet and Mebacid 200 dosage calculation problems].
    Losch K; Heinze W; Mieth K
    Arch Exp Veterinarmed; 1980; 34(4):573-8. PubMed ID: 7447601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic findings following the oral application of granulated Mebacid in cattle, calves and sheep].
    Losch K; Mieth K; Lender S
    Arch Exp Veterinarmed; 1981; 35(1):109-13. PubMed ID: 7224787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses.
    Nouws JF; Firth EC; Vree TB; Baakman M
    Am J Vet Res; 1987 Mar; 48(3):392-402. PubMed ID: 3565894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of the sulfonamide-trimethoprim combinations Berlocombin and Sulprim in patients with various degrees of kidney dysfunction].
    Günther K; Traeger A; Stein G
    Pharmazie; 1984 Apr; 39(4):250-3. PubMed ID: 6610881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacokinetics of sulfamerazine after a single intravenous dose in healthy calves and calves with diarrhea of different severity with consideration of the influence of an existing kidney function restriction].
    Barthel G
    Dtsch Tierarztl Wochenschr; 1993 Apr; 100(4):152-6. PubMed ID: 8486092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New investigation of the pharmacokinetics of nalidixic acid. I. Serum and urinary levels with normal renal function].
    Brühl P; Gundlach G; Wintjes K; Eichner W; Bastian HP
    Arzneimittelforschung; 1973 Sep; 23(9):1311-3. PubMed ID: 4801227
    [No Abstract]   [Full Text] [Related]  

  • 16. [Initial results of a clinical trial of Mebacid (sulfamerazine) in the drug therapy of bacterial meningitis].
    Loebe FM; Günther J
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():43-8. PubMed ID: 829634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetic model studies of sulfamerazine in domestic mammals. 1. Elimination of Mebacid 200 following intravenous administration to large animals].
    Losch K; Heinze W; Mieth K; Lender S
    Arch Exp Veterinarmed; 1980; 34(3):443-9. PubMed ID: 7436676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic studies of sulfamerazine-Na, sulfaperine-Na and sulfadimidine-Na in the hen].
    Losch K
    Arch Exp Veterinarmed; 1980; 34(4):587-94. PubMed ID: 7447603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dosage of drugs in patients with kidney diseases].
    Kokot F
    Wiad Lek; 1996; 49(7-12):87-91. PubMed ID: 9245115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of cefamandole in patients with reduced renal function.
    Czerwinski AW; Pederson JA
    Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.